PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10600776-8	1999	Cytochalasin D also induced MARCKS translocation and enhanced PMA-stimulated translocation of MARCKS.	Cytochalasin D	0-14	myristoylated alanine rich protein kinase C substrate	Homo sapiens	28-34	
10600776-8	1999	Cytochalasin D also induced MARCKS translocation and enhanced PMA-stimulated translocation of MARCKS.	Cytochalasin D	0-14	myristoylated alanine rich protein kinase C substrate	Homo sapiens	94-100	
9150270-3	1997	CD treatment for 1 h disrupted F-actin filaments, increased membrane bound immunoreactive MARCKS (from 51% to 62% of total), yet markedly enhanced the amount of MARCKS translocated to the cytosolic fraction in response to the phorbol ester 4beta-12-O-tetradecanoylphorbol 13-acetate.	Cytochalasin D	0-2	myristoylated alanine rich protein kinase C substrate	Homo sapiens	90-96	
9150270-3	1997	CD treatment for 1 h disrupted F-actin filaments, increased membrane bound immunoreactive MARCKS (from 51% to 62% of total), yet markedly enhanced the amount of MARCKS translocated to the cytosolic fraction in response to the phorbol ester 4beta-12-O-tetradecanoylphorbol 13-acetate.	Cytochalasin D	0-2	myristoylated alanine rich protein kinase C substrate	Homo sapiens	161-167	
9150270-6	1997	Staurosporine inhibited the phorbol ester-induced translocation of MARCKS but not of PKC alpha in both CD pretreated and untreated cells.	Cytochalasin D	103-105	myristoylated alanine rich protein kinase C substrate	Homo sapiens	67-73